Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2011, Article ID 841054, 9 pages
http://dx.doi.org/10.1155/2011/841054
Research Article

A Novel Domperidone Hydrogel: Preparation, Characterization, Pharmacokinetic, and Pharmacodynamic Properties

1Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
2State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China

Received 11 September 2010; Accepted 29 November 2010

Academic Editor: Yellela S. R. Krishnaiah

Copyright © 2011 Chun-Hui Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Ahmad, J. Keith-Ferris, E. Gooden, and T. Abell, “Making a case for domperidone in the treatment of gastrointestinal motility disorders,” Current Opinion in Pharmacology, vol. 6, no. 6, pp. 571–576, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. S. Nagarsenker, S. D. Garad, and G. Ramprakash, “Design, optimization and evaluation of domperidone coevaporates,” Journal of Controlled Release, vol. 63, no. 1-2, pp. 31–39, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. Reddymasu, I. Soykan, and R. W. McCallum, “Domperidone: review of pharmacology and clinical applications in gastroenterology,” American Journal of Gastroenterology, vol. 102, no. 9, pp. 2036–2045, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. S. T. Prajapati, L. D. Patel, and D. M. Patel, “Gastric floating matrix tablets: design and optimization using combination of polymers,” Acta Pharmaceutica, vol. 58, no. 2, pp. 221–229, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. B. C. Hancock and M. Parks, “What is the true solubility advantage for amorphous pharmaceuticals?” Pharmaceutical Research, vol. 17, no. 4, pp. 397–404, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. S. B. Murdande, M. J. Pikal, R. M. Shanker, and R. H. Bogner, “Solubility advantage of amorphous pharmaceuticals: I. a thermodynamic analysis,” Journal of Pharmaceutical Sciences, vol. 99, no. 3, pp. 1254–1264, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. P. Gupta, G. Chawla, and A. K. Bansal, “Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility,” Mol Pharm, vol. 1, no. 6, pp. 406–413, 2004. View at Google Scholar · View at Scopus
  8. K. A. Overhoff, J. T. McConville, W. Yang, K. P. Johnston, J. I. Peters, and R. O. Williams III, “Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing,” Pharmaceutical Research, vol. 25, no. 1, pp. 167–175, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. L. Raghavan, A. Trividic, A. F. Davis, and J. Hadgraft, “Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate,” International Journal of Pharmaceutics, vol. 193, no. 2, pp. 231–237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Hörter and J. B. Dressman, “Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract,” Advanced Drug Delivery Reviews, vol. 46, no. 1-3, pp. 75–87, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. DiNunzio, D. A. Miller, W. Yang, J. W. McGinity, and R. O. Williams III, “Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole,” Molecular Pharmaceutics, vol. 5, no. 6, pp. 968–980, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. D. A. Miller, J. C. DiNunzio, W. Yang, J. W. McGinity, and R. O. Williams III, “Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition,” Drug Development and Industrial Pharmacy, vol. 34, no. 8, pp. 890–902, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. D. A. Miller, J. C. DiNunzio, W. Yang, J. W. McGinity, and R. O. Williams III, “Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption,” Pharmaceutical Research, vol. 25, no. 6, pp. 1450–1459, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. K. A. Overhoff, A. Moreno, D. A. Miller, K. P. Johnston, and R. O. Williams III, “Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing,” International Journal of Pharmaceutics, vol. 336, no. 1, pp. 122–132, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. J. M. Vaughn, J. T. McConville, D. Burgess et al., “Single dose and multiple dose studies of itraconazole nanoparticles,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 63, no. 2, pp. 95–102, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. E. Matteucci, B. K. Brettmann, T. L. Rogers, E. J. Elder, R. O. Williams III, and K. P. Johnston, “Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media,” Molecular Pharmaceutics, vol. 4, no. 5, pp. 782–793, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. E. Matteucci, J. C. Paguio, M. A. Miller, R. O. Williams III, and K. P. Johnston, “Flocculated amorphous nanoparticles for highly supersaturated solutions,” Pharmaceutical Research, vol. 25, no. 11, pp. 2477–2487, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. E. Matteucci, J. C. Paguio, M. A. Miller, R. O. Williams III, and K. P. Johnston, “Highly supersaturated solutions from dissolution of amorphous ltraconazole microparticles at pH 6.8,” Molecular Pharmaceutics, vol. 6, no. 2, pp. 375–385, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. Janssens, S. Nagels, H. N. D. Armas, W. D'Autry, A. Van Schepdael, and G. Van den Mooter, “Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 69, no. 1, pp. 158–166, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. E. Karavas, E. Georgarakis, M. P. Sigalas, K. Avgoustakis, and D. Bikiaris, “Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 66, no. 3, pp. 334–347, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. T. Sanz Taberner, A. Martín-Villodre, J. M. Pla-Delfina, and J. V. Herráez, “Consistency of Carbopol 971-P NF gels and influence of soluble and cross-linked PVP,” International Journal of Pharmaceutics, vol. 233, no. 1-2, pp. 43–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Bonacucina, S. Martelli, and G. F. Palmieri, “Rheological, mucoadhesive and release properties of Carbopol gels in hydrophilic cosolvents,” International Journal of Pharmaceutics, vol. 282, no. 1-2, pp. 115–130, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. G. Bonacucina, M. Cespi, M. Misici-Falzi, and G. F. Palmieri, “Rheological, adhesive and release characterisation of semisolid Carbopol/tetraglycol systems,” International Journal of Pharmaceutics, vol. 307, no. 2, pp. 129–140, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. R. A-sasutjarit, A. Sirivat, and P. Vayumhasuwan, “Viscoelastic properties of Carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases,” Pharmaceutical Research, vol. 22, no. 12, pp. 2134–2140, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. H. Müller and C. Jacobs, “Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability,” International Journal of Pharmaceutics, vol. 237, no. 1-2, pp. 151–161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kobylińska and K. Kobylińska, “High-performance liquid chromatographic analysis for the determination of domperidone in human plasma,” Journal of Chromatography B, vol. 744, no. 1, pp. 207–212, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Liu, R. Wan, X. F. Xu et al., “Effect of Lianshu preparation on lipopolysaccharide-induced diarrhea in rats,” World Journal of Gastroenterology, vol. 15, no. 16, pp. 2009–2015, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. K. Singla, M. Chawla, and A. Singh, “Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review,” Drug Development and Industrial Pharmacy, vol. 26, no. 9, pp. 913–924, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Barreiro-Iglesias, C. Alvarez-Lorenzo, and A. Concheiro, “Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels,” Journal of Controlled Release, vol. 77, no. 1-2, pp. 59–75, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Ozeki, H. Yuasa, and Y. Kanaya, “Controlled release from solid dispersion composed of poly(ethylene oxide)-Carbopol interpolymer complex with various cross-linking degrees of Carbopol,” Journal of Controlled Release, vol. 63, no. 3, pp. 287–295, 2000. View at Publisher · View at Google Scholar · View at Scopus